Scott M. Pittman Nuo Therapeutics, Inc. (AURX) insider trading activity

AURX Quotes by TradingView

Scott M. Pittman is Director of Nuo Therapeutics, Inc.. Currently has a direct ownership of 5.4 Million shares of AURX, which is worth approximately $11.4 Million. The most recent transaction as insider was on Jul 30, 2025, when has been sold 3,946 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $5,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.4M
0% 3M change
0.07% 12M change
Total Value Held $11.4 Million

Scott M. Pittman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2025
BUY
Grant, award, or other acquisition
$5,919 $1.5 p/Share
3,946 Added 0.07%
5,400,000 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
$93,614 $0.43 p/Share
217,709 Added 3.88%
5,396,054 Common Stock
May 20 2024
BUY
Grant, award, or other acquisition
$101,250 $0.75 p/Share
135,000 Added 2.54%
5,178,345 Common Stock
Dec 19 2023
BUY
Grant, award, or other acquisition
$300,000 $0.5 p/Share
600,000 Added 10.63%
5,043,345 Common Stock
Aug 01 2023
BUY
Grant, award, or other acquisition
$200,000 $2.0 p/Share
100,000 Added 2.2%
4,443,345 Common Stock
Apr 29 2022
BUY
Grant, award, or other acquisition
$100,000 $1.0 p/Share
100,000 Added 2.25%
4,343,345 Common Stock
SMP

Scott M. Pittman

Director
Houston, TX

Track Institutional and Insider Activities on AURX

Follow Nuo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURX shares.

Notify only if

Insider Trading

Get notified when an Nuo Therapeutics, Inc. insider buys or sells AURX shares.

Notify only if

News

Receive news related to Nuo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AURX